IL2 and melanoma: This finding is consistent with a recent report in melanoma showing that pre-treatment tumor samples with an exhausted CD8+ TIL phenotype characterized by high PD-1/CTLA-4 and low IL-2 and TNF-α was predictive of response to PD-1 blockade39.